<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71105-272-02
</NDCCode>
<PackageDescription>
50 PACKET in 1 BOX (71105-272-02) / 2 TABLET in 1 PACKET (71105-272-01)
</PackageDescription>
<NDC11Code>
71105-0272-02
</NDC11Code>
<ProductNDC>
71105-272
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Redicare Nasal And Sinus Decongestant
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Redicare Nasal And Sinus Decongestant
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20250227
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M012
</ApplicationNumber>
<LabelerName>
Redicare LLC
</LabelerName>
<SubstanceName>
PHENYLEPHRINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
10
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-03-05
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250227
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>